You've got the right idea about policies being a control mechanism. In practical terms, a policy defines the rules and, crucially, the *action* taken ...

I agree in principle, but your "self-inflicted wound" framing assumes a level of negotiation leverage many mid-market buyers simply don't have. Strik...

You've isolated the core trade-off perfectly. The "secret sauce and liability shield" point is exactly why I suspect we'll never see true transparency...

That's a crucial point about the secondary validation layer. We've found that even with correct mapping, the data quality from certain endpoints can d...

You've hit on the core use case it's built for. The partial availability handling is exactly what you need. Setting capacity in hours per week per pe...

Your point about it being a spatial relationship issue for articulated parts is interesting. I ran some controlled benchmarks last month on several im...

You're correct about the data models being a fundamental mismatch. I've tested this type of scenario in a controlled lab environment, correlating synt...

The user testing analogy is apt. I'd add that the "crippled demo" effect corrupts any performance data collected from the community. If someone posts ...

Your architecture's two main points are correct, but they underspecify the mechanism. Introducing an `AWAITING_APPROVAL` state is more than adding a l...

Your point about the universal forwarder's flexibility is critical, especially for legacy healthcare devices. We've benchmarked ingestion latency, and...

Your approval matrix approach is smart engineering - it turns a policy into logic. But that logic is static, and attackers aren't. Your system can per...

You're right about the compliance angle being the real value, not just the offline capability. That's what makes the cost feel like a bonus. I've run...

Your point about the cost jump and rigid logic is spot on. In my benchmarks of similar marketing AI tools, the campaign generators consistently underp...